CEO of Providence Therapeutics, Brad Sorenson, joins Linda Olsen to discuss a new COVID-19 vaccine developed by the Calgary-based company as it heads into human clinical trials.
Canada
Calgary-based company’s COVID-19 vaccine heading into human clinical trials
More Videos
-
Can parking and vehicle fees support public transit in Calgary?
-
Stanley Cup playoffs: Are the Edmonton Oilers really Canada’s team?
-
Global News Hour at 6 Calgary: May 23
-
Calgary Hitmen hire former Seattle Kraken assistant Paul McFarland as head coach
-
Calgary swimming community concerned about impacts of Inglewood pool closure
-
Cost of airfare in Canada skyrockets ahead of summer
You are viewing an Accelerated Mobile Webpage.
View Original Article